BioSpace News Archive

Growing advancements in medical and clinical field has spread awareness about requirement for better healthcare system. Governments across the globe are making amendments in research & development, and diagnostic activities, and taking initiatives for developing access to care.

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has successfully executed a binding funding agreement with leading institutional investors to raise $200 million a

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O’Connor , President and Chief Executive Officer of OncoSec, will present a company overview at the Virtual Summer Investor Summit on Tuesday, J

Scality, a leader in software solutions for global data orchestration and distributed file and object storage today reported how the Scality RING brings unique efficiencies in today’s modern healthcare and genomic data centers.

Dr. Majid Fotuhi, MD, PhD, a nationally-recognized neurologist, is warning about neurological issues in patients who suffer from COVID-19

AmorChem is proud to announce a new investment in a research program hailing from Université Laval and the Research Center of the Centre Hospitalier Universitaire de Québec. The venture capital fund identified the opportunity in close collaboration with SOVAR, a group active in the promotion of university research. Am

Capricor Therapeutics (“Capricor”) (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment and prevention of diseases, announced today that it will be participating in the upcoming BIO Digital International Convention. Details: Event: BIO Digital 2020 Date: J

Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today the submission to an international medical journal the results of pre-clinical and clinical evaluation of QuadraMune™ in 32 healthy

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Kathleen McGroddy-Goetz, Ph.D., as an independent member of its Board of Directors effective June 8, 2020. Dr. McGroddy-Goetz has extensive experience commercializing pioneering technologies spanning from microelectronics through cloud, advanced data analytics, AI, hardware, software, and mid

A premier data analytics and advisory firm, Quantzig, has announced the completion of its latest success story that highlights how a leading medical implants manufacturer used sales force effectiveness to develop new sales models. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200604005244/en/ This success story offers in-depth insights into Quantzig’s sales